Zobrazeno 1 - 10
of 22
pro vyhledávání: '"REIKO TASAKA"'
Autor:
Ken-ichi Honda, Masato Miyama, Yuko Nishii, Reiko Tasaka, Yusuke Nakano, Naohiko Umesaki, Takeshi Fukuda, Tomoyuki Ichimura, Tomoyo Yasui, Toshiyuki Sumi
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-5 (2024)
Abstract Background In patient assessment for recurrence of neoplasia, a biomarker that shows an elevated serum value before the first treatment is a candidate for follow-up examination. The biomarker squamous cell carcinoma antigen is usually utiliz
Externí odkaz:
https://doaj.org/article/8ca9c1c97186434ea3c26e94316cd4d1
Autor:
EIJIRO UCHIKURA, TAKESHI FUKUDA, TOMOKI SENGIKU, TAKUYA NODA, YUICHIRO AWAZU, TAKUMA WADA, REIKO TASAKA, MAKOTO YAMAUCHI, TOMOYO YASUI, TOSHIYUKI SUMI
Publikováno v:
Oncology Letters; Nov2024, Vol. 28 Issue 5, p1-8, 8p
Autor:
REIKO TASAKA1, TAKESHI FUKUDA1 takeshif@med.osaka-cu.ac.jp, TAKUMA WADA1, MASARU KAWANISHI1, KENJI IMAI1, MARI KASAI1, YASUNORI HASHIGUCHI1, TOMOYUKI ICHIMURA1, TOMOYO YASUI1, TOSHIYUKI SUMI1
Publikováno v:
Molecular & Clinical Oncology. 2017, Vol. 6 Issue 3, p373-376. 4p.
Autor:
Takeshi Fukuda, Toshiyuki Sumi, Kenji Imai, Masaru Kawanishi, Takuma Wada, Tomoyo Yasui, Reiko Tasaka
Publikováno v:
Oncology Letters. 14:951-957
Concurrent chemoradiotherapy is the standard treatment for locally advanced uterine cervical cancer. However, effective neoadjuvant chemotherapy (NAC) can reduce tumor size and facilitate hysterectomy for locally advanced uterine cervical cancer. NAC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae16ea0f5799fdbf1259ff814453aa40
https://doi.org/10.3892/ol.2017.6212
https://doi.org/10.3892/ol.2017.6212
Autor:
Masaru Kawanishi, Reiko Tasaka, Toshiyuki Sumi, Kenji Imai, Takeshi Fukuda, Mari Kasai, Yasunori Hashiguchi, Tomoyuki Ichimura, Takuma Wada, Tomoyo Yasui, Makoto Yamauchi
Publikováno v:
Biomedical Reports. 5:199-202
Opportunities for patients undergoing hemodialysis to receive chemotherapy are increasing. A combination of paclitaxel and carboplatin (TC) is first-line chemotherapy in patients with Müllerian cancer. However, the optimal dose and time interval bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9065b28012fd3642fa83abd2ec7f476
https://doi.org/10.3892/br.2016.714
https://doi.org/10.3892/br.2016.714
Autor:
Kenji Yoshikawa, Tomoyo Yasui, Hiroaki Matsubara, Ryo Uemura, Mari Kasai, Toshiyuki Sumi, Masaru Kawanishi, Takeshi Fukuda, Reiko Tasaka, Takuma Wada, Tomoyuki Ichimura, Yasunori Hashiguchi
Approximately 40% of all patients with ovarian cancer in Japan are aged ≥65 years. The aim of the present study was to evaluate the differences in prognosis and prognostic factors between elderly and younger patients with epithelial ovarian cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11772a7cc824156a926f8acfd2f4c8b5
https://europepmc.org/articles/PMC6090571/
https://europepmc.org/articles/PMC6090571/
Autor:
Masaru Kawanishi, Toshiyuki Sumi, Tomoyo Yasui, Masahiro Shimomura, Reiko Tasaka, Takeshi Fukuda, Yuta Inoue, Takuma Wada
The standard treatment for ovarian serous carcinoma is maximum debulking surgery and platinum-based chemotherapy. Despite the high response rate for chemotherapy, the majority of patients will be resistant to first-line agents and the prognosis for t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b68b97048b84b3e0552be69e980189a
https://europepmc.org/articles/PMC6004649/
https://europepmc.org/articles/PMC6004649/
Autor:
Yuta Inoue, Masahiro Shimomura, Toshiyuki Sumi, Kazuo Ikeda, Tomoyo Yasui, Takuma Wada, Takeshi Fukuda, Masaru Kawanishi, Reiko Tasaka
Publikováno v:
Oncology Letters.
The standard treatment for locally advanced uterine cervical cancer is concurrent chemoradiotherapy. Successful neoadjuvant chemotherapy (NAC) may reduce tumor size and facilitate a hysterectomy, thereby improving the prognosis for patients with loca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c551b5718ec96551541ad345318d2de
https://doi.org/10.3892/ol.2018.7810
https://doi.org/10.3892/ol.2018.7810
Autor:
Masahiro Shimomura, Tomoyo Yasui, Toshiyuki Sumi, Yuta Inoue, Masaru Kawanishi, Reiko Tasaka, Takuma Wada, Takeshi Fukuda
Publikováno v:
Oncology Letters.
The standard treatment for ovarian serous carcinoma comprises maximum debulking surgery and platinum-based chemotherapy. Despite the high response rate to chemotherapy, the majority of patients will be resistant to first-line agents and the prognosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa3223646239d349c1e5c29aa441a382
https://doi.org/10.3892/ol.2017.7719
https://doi.org/10.3892/ol.2017.7719
Autor:
Reiko Tasaka, Mari Kasai, Tomoyo Yasui, Toshiyuki Sumi, Kenji Imai, Takeshi Fukuda, Masaru Kawanishi, Takuma Wada, Yasunori Hashiguchi, Tomoyuki Ichimura
Publikováno v:
Molecular and clinical oncology. 6(3)
Vaginal melanoma is a rare tumor, accounting for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1536c0521b882ba7e335e06fe535157
https://pubmed.ncbi.nlm.nih.gov/28451415
https://pubmed.ncbi.nlm.nih.gov/28451415